Volume Stages Pilot 500-1,000 units For: formula lock, Amazon/DTC test, pack check Gate: liposome integrity / GSH/GSSG retention / sensory / seal integrity First commercial 5,000-10,000 units For: regional / e-comm launch Gate: batch reproducibility / pack-line validation / accelerated stability Note: qualified private-label entry commonly starts around 3,000-5,000 units depending on format Full-scale 100,000+ units For: retail / export programs Gate: sourcing continuity / cost structure / QC reproducibility across reorders Format MOQ & Lead Time (Confirm Per Project) Capsules: from 5,000 units / 4-6 weeks Softgels: from 10,000 units / 5-7 weeks Stick packs: from 10,000 units / 5-7 weeks Gummies: from 10,000 units / 6-8 weeks Liquids: project-scoped / typically 5-8 weeks after formula lock What Moves Price Beyond MOQ GSH grade and dose / phospholipid system / encapsulation depth / barrier packaging / contaminant panel / rush schedule / multi-market label packs What Moves Scale Timing Sell-through data / regional clearance status/phospholipid and GSH availability/channel expansion needs Predictable cycle with exit criteria at each gate

Custom-compounded for stability
However, the specific mechanism of GPx4 in the occurrence of breast cancer has not been elucidated and requires further study
The apoptosis/autophagy paradox: autophagic vacuolization before apoptotic death
It was reported that broad-spectrum glutamine antagonists are more effective in promoting tumor regression than selectively inhibiting a single glutaminase (Hensley et al., 2013)
NaLXLiYPanHZet al